Cite

    Ding, X., Li, X., Qin, A., Zhou, J., Yan, D., Stevens, C., Krauss, D., & Kabolizadeh, P. (2018). have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer. Acta oncologica, 57, 435–437. http://access.bl.uk/ark:/81055/vdc_100092179051.0x00004a